top of page

HUMAN CELLULAR MODEL SYSTEMS

For compound screening and

neuroscience research

WELCOME TO NEURIX

Welcome to Neurix

There are currently more than 600 diseases characterized as affecting the central nervous system which inflict neural damage. Unfortunately, few of these conditions have effective treatments available. Neurix is committed to pursue innovation and breakthrough technologies to disrupt the negative trend.

NEWS, EVENTS & INNOVATIONS

Screenshot 2023-05-03 at 12.07.59.png

Neuro-oncology press release

Our glioblastoma in vitro model,  BlastomaBrain™, selected for pre-clinical development in preparation for an FDA IND submission.

Screenshot 2022-10-16 at 21.11.52.png

Neuroscience and Biotech: What’s Next?

Join us for a series of talks from industry experts about Neuroscience and Biotech. Get the insights on what to expect in 2022 and beyond.

Transcend.jpg

Transcend consortium for Parkinon's disease model

Neurix develops a microglia-embedded cerebral organoid model of Parkinson's disease, in collaboration with Innoser and the University of Geneva

WE KEEP YOU UPDATED

You want to hear about the last advances of our technology ? Please provide us you contact details to keep you updated. 

3-DIMENSIONAL NEURAL TISSUE

Neurix provides services for drug discovery and development. We generate physiologically relevant 3-dimensional neural tissues derived from human pluripotent stem cells. Our organoids display accelerated cell maturity that mimic the native brain tissue. Predictive, accurate and reproducible, our in vitro human cell-based services enable scientists to quickly and economically conduct research with improved outcomes in a simplified workflow.
 

We generate two formats of neural organoids to ensure compatibility with high troughtput screening, and optimal disease modeling services

Minibrain.png

MiniBrain

TM

- Injectable

- Full genomic / proteomic analysis

Neuropheres.jpg

Neurosphere

- High throughput compatible

OUR SERVICES 

Neurix provides human stem cell-based services for neural drug screening and lead compound validation including Efficacy & Drug Discovery services, as well as Cell Models.

Blastomabrain.jpg

BlastomaBrain      Glioblastoma invasion model

Glioblastoma invading neural organoids to asses drug efficiency on tumor growth, motility and metastasis.

TM

virionbrain.jpg

TM

VirionBrain      Gene therapy testing
                                Virus invasion model

Assessing the efficiency for gene therapies and anti-viral drug compounds.

Cellbrain.jpg

CellBrain    Cell therapy testing

                            Biomaterial therapy testing

Testing the efficiency of cell therapy, cell survival and integration inside the neural tissue

TM

Image custom.jpg

Personalized service

Neurix offers drug discovery services and personalized development of in vitro disease models, assays, and in dept -omic analyses. 

bottom of page